4.5 Article

Regional expression of genes mediating trans-synaptic alpha-synuclein transfer predicts regional atrophy in Parkinson disease

Journal

NEUROIMAGE-CLINICAL
Volume 18, Issue -, Pages 456-466

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.nicl.2018.01.009

Keywords

Parkinson disease; LAG3; Alpha-synuclein; Trans-synaptic spread; Atrophy; Genetic analysis

Categories

Funding

  1. Michael J. Fox Foundation
  2. Abbvie
  3. Avid Radiopharmaceuticals
  4. Biogen Idec
  5. BioLegend
  6. Bristol-Myers Squibb
  7. Eli Lilly and Company
  8. F. Hoffmann-La Roche Ltd.
  9. GE Healthcare
  10. Genentech
  11. GlaxoSmithKline
  12. Lundbeck Foundation
  13. Merck
  14. MesoScale Discovery
  15. Piramal
  16. Pfizer
  17. Sanofi Genzyme
  18. Servier
  19. Takeda
  20. Teva
  21. UCB
  22. NIH [R01NS092802]

Ask authors/readers for more resources

Multiple genes have been implicated in Parkinson disease pathogenesis, but the relationship between regional expression of these genes and regional dysfunction across the brain is unknown. We address this question by joint analysis of high resolution magnetic resonance imaging data from the Parkinson's Progression Markers Initiative and regional genetic microarray expression data from the Allen Brain Atlas. Regional brain atrophy and genetic expression was co-registered to a common 86 region brain atlas and robust multivariable regression analysis was performed to identify genetic predictors of regional brain atrophy. Top candidate genes from GWAS analysis, as well as genes implicated in trans-synaptic alpha-synuclein transfer and autosomal recessive PD were included in our analysis. We identify three genes with expression patterns that are highly significant predictors of regional brain atrophy. The two most significant predictors are LAG3 and RAB5A, genes implicated in transsynaptic synuclein transfer. Other well-validated PD-related genes do not have expression patterns that predict regional atrophy, suggesting that they may serve other roles such as disease initiation factors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available